These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 32202208)
21. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Bjornevik K; Münz C; Cohen JI; Ascherio A Nat Rev Neurol; 2023 Mar; 19(3):160-171. PubMed ID: 36759741 [TBL] [Abstract][Full Text] [Related]
22. Siblings reduce multiple sclerosis risk by preventing delayed primary Epstein-Barr virus infection. Rostgaard K; Nielsen NM; Melbye M; Frisch M; Hjalgrim H Brain; 2023 May; 146(5):1993-2002. PubMed ID: 36317463 [TBL] [Abstract][Full Text] [Related]
23. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis. Otto C; Hofmann J; Ruprecht K Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157 [TBL] [Abstract][Full Text] [Related]
24. Low sun exposure acts synergistically with high Epstein-Barr nuclear antigen 1 (EBNA-1) antibody levels in multiple sclerosis etiology. Hedström AK; Huang J; Brenner N; Butt J; Kockum I; Waterboer T; Olsson T; Alfredsson L Eur J Neurol; 2021 Dec; 28(12):4146-4152. PubMed ID: 34435414 [TBL] [Abstract][Full Text] [Related]
25. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321 [TBL] [Abstract][Full Text] [Related]
26. Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study. Bjørnevik K; Riise T; Bostrom I; Casetta I; Cortese M; Granieri E; Holmøy T; Kampman MT; Landtblom AM; Magalhaes S; Pugliatti M; Wolfson C; Myhr KM Mult Scler; 2017 Jun; 23(7):1018-1024. PubMed ID: 27663872 [TBL] [Abstract][Full Text] [Related]
27. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Nielsen TR; Rostgaard K; Askling J; Steffensen R; Oturai A; Jersild C; Koch-Henriksen N; Sørensen PS; Hjalgrim H Mult Scler; 2009 Apr; 15(4):431-6. PubMed ID: 19153174 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr Virus (EBV) and Multiple Sclerosis Disease: A Biomedical Diagnosis. Alanazi A Comput Intell Neurosci; 2022; 2022():3762892. PubMed ID: 36082345 [TBL] [Abstract][Full Text] [Related]
29. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands. Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238 [TBL] [Abstract][Full Text] [Related]
30. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait. Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919 [TBL] [Abstract][Full Text] [Related]
31. High Levels of Epstein-Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk. Hedström AK; Huang J; Michel A; Butt J; Brenner N; Hillert J; Waterboer T; Kockum I; Olsson T; Alfredsson L Front Neurol; 2019; 10():1368. PubMed ID: 32038456 [No Abstract] [Full Text] [Related]
32. Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection. Hedström AK Front Immunol; 2023; 14():1212676. PubMed ID: 37554326 [TBL] [Abstract][Full Text] [Related]
36. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis. Huang J; Tengvall K; Bomfim Lima I; Hedström AK; Butt J; Brenner N; Gyllenberg A; Stridh P; Khademi M; Ernberg I; Al Nimer F; Manouchehrinia A; Hillert J; Alfredsson L; Andersen O; Sundström P; Waterboer T; Olsson T; Kockum I Brain; 2024 Apr; ():. PubMed ID: 38630618 [TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies. Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546 [TBL] [Abstract][Full Text] [Related]
38. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; James JA Mult Scler; 2013 Jun; 19(7):891-5. PubMed ID: 23232601 [TBL] [Abstract][Full Text] [Related]
39. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Pakpoor J; Disanto G; Gerber JE; Dobson R; Meier UC; Giovannoni G; Ramagopalan SV Mult Scler; 2013 Feb; 19(2):162-6. PubMed ID: 22740437 [TBL] [Abstract][Full Text] [Related]